The European Union granted Pulmatrix Inc. (Nasdaq: PULM) a patent for its inhaled drug delivery technology iSPERSE sending the stock price soaring $1.10 to close at $3.88.
EU grants patent to Pulmatrix
March 21, 2017 at 18:16 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.